FDMT
4D Molecular Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.29
+1.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 41.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.67x
- Price / sales
- 7.38x
- Price / cash flow
- -4.35x
Enterprise value
- Enterprise value
- $356.8M
- EV / sales
- 3.88x
- EV / EBITDA
- -1.94x
- EV / EBIT
- -1.81x
- Market cap
- $679.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026